Jackson Harvey, Ph.D., is Analyst on the Biotherapeutics group at Deerfield and joined the Firm in 2021. Prior to Deerfield, Dr. Harvey was a research analyst at Stifel. Before Stifel, he was a Biotech Equity Research Associate for Deutsche Bank and before that, Nomura/Instinet. Dr. Harvey holds a B.S. in Biochemistry and Philosophy from Binghamton University and a Ph.D. in Pharmacology from the Weill Cornell Graduate School of Medical Sciences.